(Q36710152)

15 August 2017

1 reference

title

Biochemical assessment of Paget's disease of bone (English)

1 reference

15 August 2017

Subramanian Shankar

1

1 reference

PubMed ID

17229003

15 August 2017

David J Hosking

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

Journal of Bone and Mineral Research

15 August 2017

1 reference

15 August 2017

21 Suppl 2

1 reference

15 August 2017

P22-7

1 reference

Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.

15 August 2017

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.06S204

21 January 2018

Identifiers

DOI

10.1359/JBMR.06S204

1 reference

15 August 2017

1 reference

PubMed ID

17229003